The Technology

Negative-Pressure Stabilized Injection Architecture

Biopreme has developed a patented injection adapter that introduces negative-pressure tissue stabilization and fixed-depth mechanical guidance into subcutaneous injection delivery.
The device modifies the physical interface between syringe, needle, and tissue to create a controlled and repeatable injection environment independent of user technique.

Design Objectives

Our technology is engineered to address fundamental mechanical limitations of conventional subcutaneous injection, namely:

Depth Control

Optimal diffusion and uptake are dependent on reliable, penetration depths no matter the clinician or their expertise.

Tissue Stabilization

Multiple factors contribute to unstable injection conditions that cause pain and inadvertent needle sticks.

Needle Concealment

Studies clearly show that anticipated pain amplifies actual pain and causes patient flinching and tension.

Mechanical Guide

Case load pressure and learned habits often result in sub-optimal manual guidance of injections in busy clinics.

Biopreme’s architecture introduces mechanical controls that replace manual variability with defined physical parameters.

System Architecture

Biopreme’s adapter consists of three integrated functional subsystems. These subsystems operate sequentially and synergistically during injection.

  • A

    Negative-pressure stabilization chamber

  • B

    Fixed-depth penetration channel

  • C

    Needle concealment housing

Illustration

Mechanism of Operation

This sequence produces a mechanically guided injection event with reduced dependence on user technique

Illustration

Attach to Syringe

The adapter is attached to a standard syringe and needle assembly.

Illustration

Skin Contact

Upon contact with skin, gentle negative pressure is generated within the stabilization chamber.

Illustration

Negative Pressure Engages

Tissue is drawn into a defined geometry, limiting lateral and vertical movement.

Illustration

Fixed-Depth Guidance

A fixed-depth channel guides needle advancement to a predetermined subcutaneous depth (3mm).

Illustration

Injection Delivery

The needle remains concealed within the housing until tissue engagement occurs.

Illustration

Negative-Pressure Stabilization

Negative pressure serves two primary mechanical functions:

    Creates secure purchase on the injection site

    Reduces tissue displacement during penetration

Stabilization improves consistency of needle entry angle and depth while reducing the likelihood of partial insertion or deflection.

Fixed-Depth Mechanical Guidance

The adapter incorporates a depth-regulating channel that physically limits needle penetration to a predetermined subcutaneous depth. Benefits include:

    Reduced risk of accidental intramuscular delivery

    Improved consistency across patient body types

    Reduced reliance on clinician estimation

Illustration

Needle Concealment

The needle is enclosed within the adapter housing prior to engagement with tissue. This configuration:

Eliminates pre-insertion needle visibility

Reduces visual stimulus associated with anxiety | Supports calmer patient experience

Performance Characteristics

Consistent Depth Control

Stable, Gentle, Tissue Capture

Repeatable Mechanical Guidance

Compatible With Standard Syringes

*Bench-level performance data available.

Compatibility

    Designed to interface with standard syringe and needle formats

    Does not alter drug formulation or syringe design

    Single-use disposable adapter

Safety Benefits

Reduced Blood & Drug Exposure

Mitigated Patient Injury

Minimize clinician needle sticks

Intended Use Environments

Pediatric Immunization Programs

Pediatric Outpatient Therapy

Self-Injected Therapies in Home  

Geriatric and Long Term Care Facilities

•SET8-v2

Specialty Clinics and Pharmacy Vaccine Centers

Platform Applications

The negative-pressure stabilization architecture is applicable to any subcutaneous injection scenario requiring:Controlled penetration depth · Tissue stabilization · Reduced visual needle exposureThis architecture supports adaptation across multiple therapeutic areas and care settings.

Illustration
Illustration

Intellectual Property

Biopreme holds issued patents covering negative-pressure stabilized injection and depth-regulated delivery mechanisms, protecting the core mechanical architecture and method of use.

Request Additional Technical Information